Insider · CIK 0001856414

Marriott Tina

Reports to the SEC for 1 company · SALT LAKE CITY, UT

sec.gov

Transactions

Companies

Filings

CIK

0001856414

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-11-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−14.3K sh	$6.17	−$88.2K	506,852
2024-10-24	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+6,000 sh	$1.06	+$6,360	527,138
2024-10-24	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−6,000 sh	$6.31	−$37.9K	521,138
2024-10-24	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−6,000 sh	—	—	452,000
2024-09-26	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+6,000 sh	$1.06	+$6,360	527,138
2024-09-26	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−6,000 sh	$7.00	−$42K	521,138
2024-09-26	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	0 sh	—	—	458,000
2024-08-29	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+6,000 sh	$1.06	+$6,360	527,138
2024-08-29	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−6,000 sh	$7.56	−$45.4K	521,138
2024-08-29	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−6,000 sh	—	—	464,000
2024-08-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−14.3K sh	$6.69	−$95.8K	521,138
2024-07-25	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+6,000 sh	$1.06	+$6,360	541,457
2024-07-25	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−6,000 sh	$8.13	−$48.8K	535,457
2024-07-25	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−6,000 sh	—	—	470,000
2024-06-27	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+6,000 sh	$1.06	+$6,360	541,457
2024-06-27	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−6,000 sh	$7.21	−$43.3K	535,457
2024-06-27	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−6,000 sh	—	—	476,000
2024-05-30	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+3,000 sh	$1.06	+$3,180	538,457
2024-05-30	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−3,000 sh	$8.78	−$26.3K	535,457
2024-05-30	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	0 sh	—	—	482,000
2024-05-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−9,998 sh	$10.01	−$100K	533,233
2024-04-25	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+3,000 sh	$1.06	+$3,180	546,231
2024-04-25	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−3,000 sh	$7.67	−$23K	543,231
2024-04-25	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−3,000 sh	—	—	485,000
2024-03-21	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+8,000 sh	$1.06	+$8,480	647,982
2024-03-21	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−7,390 sh	$10.70	−$79.1K	640,592
2024-03-21	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−610 sh	$11.34	−$6,915.021	639,982
2024-03-21	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−8,000 sh	—	—	488,000
2024-02-22	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+8,000 sh	$1.06	+$8,480	647,982
2024-02-22	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−8,000 sh	$14.89	−$119K	639,982
2024-02-22	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−8,000 sh	—	—	496,000
2024-02-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−5,379 sh	$12.43	−$66.9K	639,982
2024-02-09	RXRXRECURSION PHARMACEUTICALS, INC.A Award	President and COO	AAward	+9,655 sh	—	—	424,203
2024-02-09	RXRXRECURSION PHARMACEUTICALS, INC.A Award	President and COO	AAward	+224K sh	—	—	648,161
2024-02-09	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−2,800 sh	$10.09	−$28.3K	645,361
2024-02-09	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	President and COO	AAward	+448K sh	—	—	447,917
2024-01-25	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+8,000 sh	$1.06	+$8,480	422,584
2024-01-25	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−8,000 sh	$10.35	−$82.8K	414,548
2024-01-25	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−8,000 sh	—	—	504,000
2023-12-28	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+8,000 sh	$1.06	+$8,480	422,548
2023-12-28	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−8,000 sh	$10.58	−$84.7K	414,548
2023-12-28	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−8,000 sh	—	—	512,000
2023-11-16	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+3,000 sh	$1.06	+$3,180	416,404
2023-11-16	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−3,000 sh	$6.76	−$20.3K	413,404
2023-11-16	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−3,000 sh	—	—	520,000
2023-11-15	RXRXRECURSION PHARMACEUTICALS, INC.F Tax Payment	President and COO	FTax Payment	−5,378 sh	$7.18	−$38.6K	413,404
2023-10-26	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+3,000 sh	$1.06	+$3,180	421,782
2023-10-26	RXRXRECURSION PHARMACEUTICALS, INC.S Sale	President and COO	SSale	−3,000 sh	$5.63	−$16.9K	418,782
2023-10-26	RXRXRECURSION PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	President and COO	MExercise/Conversion	−3,000 sh	—	—	523,000
2023-09-28	RXRXRECURSION PHARMACEUTICALS, INC.M Exercise/Conversion	President and COO	MExercise/Conversion	+3,000 sh	$1.06	+$3,180	421,782

Recent filings

Accepted (ET)
Nov 194
Marriott Tina0001601830-24-000213
SEC(opens sec.gov)
Oct 284
Marriott Tina0001601830-24-000181
SEC(opens sec.gov)
Sep 304
Marriott Tina0001601830-24-000161
SEC(opens sec.gov)
Sep 34
Marriott Tina0001601830-24-000150
SEC(opens sec.gov)
Aug 194
Marriott Tina0001601830-24-000128
SEC(opens sec.gov)
Jul 294
Marriott Tina0001601830-24-000105
SEC(opens sec.gov)
Jun 284
Marriott Tina0001601830-24-000095
SEC(opens sec.gov)
Jun 34
Marriott Tina0001601830-24-000068
SEC(opens sec.gov)

Companies

RECURSION PHARMACEUTICALS, INC.President and COORXRX

Address

41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101